Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue
Author(s) -
Vincenzo Di Nunno,
Giorgio Frega,
Lidia Gatto,
Giovanni Brandi,
Francesco Massari
Publication year - 2019
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2018-0758
Subject(s) - lenvatinib , medicine , sorafenib , cabozantinib , pazopanib , sunitinib , oncology , everolimus , hepatocellular carcinoma , regorafenib , cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom